Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Sign in!
Subscribe
Clinical Topics
View All
Addiction
ADHD
Anxiety
Bipolar Disorder
Depression
Emerging Approaches in Schizophrenia
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
View All
Review Article
Page 4
Recently published articles about
Review Article
JCP
Review Article
Cannabis and Anxiety/Mood Disorders
June 5, 2018
Read a full article of a systematic review on 12 studies associating cannabis use with long-term anxiety or mood disorders.
Michael Roerecke
,
Jürgen Rehm
,
George Mammen
, et al
JCP
Review Article
Youth With Autism in the Emergency Department
May 8, 2018
Families living with autism may use the emergency department to manage crises related to a variety of factors. This review summarizes current research relating to ED visits among youth...
Martha Sajatovic
,
Sarah Lytle
,
Andrew Hunt
, et al
JCP
Review Article
Psychoeducation in the Management of Bipolar Disorder
May 1, 2018
A variety of pharmacologic agents are available for treating your patients with bipolar disorder, but have you considered adding psychoeducation to your armamentarium? This review summarizes the evidence on...
Eduard Vieta
,
Roger S. McIntyre
,
Min Yi Sum
, et al
JCP
Review Article
Pharmacogenomic Testing and MDD Outcomes
June 28, 2017
In theory, pharmacogenomic testing in patients with depression can improve clinical outcomes by guiding antidepressant selection and dosing. This review looks at the current evidence to evaluate the clinical...
Roger S. McIntyre
,
Joshua D. Rosenblat
,
Yena Lee
JCP
Review Article
FDA Perspective on Pimavanserin
June 28, 2017
In 2016, pimavanserin became the only FDA-approved treatment for hallucinations and delusions associated with Parkinson's disease psychosis. This article describes the regulatory and clinical issues important to the FDA's...
Mitchell V. Mathis
,
Robert J. Temple
,
Brendan M. Muoio
, et al
JCP
Review Article
Adenosylmethionine (SAMe) for Depression
June 28, 2017
Read a systematic review on S-adenosylmethionine (SAMe) for treatment of neuropsychiatric conditions, depression, and comorbid medical conditions.
David Mischoulon
,
Anup Sharma
,
Helen Lavretsky
, et al
«
1
2
3
4
5
6
…
8
»